Long-term substitution therapy of hypogonadal men with transscrotal testosterone over 7-10 years

Clinical Endocrinology

Volumn 50, Issue 5, 1999, Pages 629-635

  Behre, Hermann M ^a   Von Eckardstein, Sigrid ^a   Kliesch, Sabine ^a   Nieschlag, Eberhard ^a  

^a INST OF REPRO MED OF THE UNIV   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; TESTOSTERONE; TRIACYLGLYCEROL;

ADULT; ARTICLE; BONE DENSITY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; ESTRADIOL BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; HYPOGONADISM; MALE; PRIORITY JOURNAL; PROSTATE; PRURITUS; SUBSTITUTION THERAPY; TESTOSTERONE BLOOD LEVEL; TRANSDERMAL DRUG ADMINISTRATION; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL;

ADMINISTRATION, CUTANEOUS; ADULT; BONE DENSITY; DIHYDROTESTOSTERONE; ESTRADIOL; FOLLOW-UP STUDIES; HUMANS; HYPOGONADISM; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; SCROTUM; TESTOSTERONE;

EID: 0032931818     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1999.00705.x     Document Type: Article

References (26)

1. Arver, S., Dobs, A.S., Meikle, A.W., Caramelli, K.E., Rjaram, L., Sanders, S.W. & Mazer, N.A. (1997) Long-term efficacy and safety of a permeation-enhanced testosterone transdermal system in hypogonadal men. Clinical Endocrinology, 47, 727-737.
2. Bals-Pratsch, M., Knuth, U.A., Yoon, Y.-D. & Nieschlag, E. (1986) Transdermal testosterone substitution therapy for male hypogonadism. Lancet, II, 943-946.
3. Bals-Pratsch, M., Langer, K., Place, V.A. & Nieschlag, E. (1988) Substitution therapy of hypogonadal men with transdermal testosterone over one year. Acta Endocrinologica, 118, 7-13.
4. Behre, H.M., Bohmeyer, J. & Nieschlag, E. (1994) Prostate volume in testosterone-treated and untreated hypogonadal men in comparison to age-matched normal controls. Clinical Endocrinology, 40, 341-349.
5. Behre, H.M., Kliesch, S., Leifke, E., Link, T.M. & Nieschlag, E. (1997) Long-term effect of testosterone therapy on bone mineral density in hypogonadal men. Journal of Clinical Endocrinology and Metabolism, 82, 2386-2390.
6. Behre, H.M., Kliesch, S., Schädel, F. & Nieschlag, E. (1995) Clinical relevance of scrotal and transrectal ultrasonography in andrological patients. International Journal of Andrology, 18 (Suppl. 2), 27-31.
7. Behre, H.M. & Nieschlag, E. (1998) Comparative pharmacokinetics of testosterone esters. In: Testosterone: Action, Deficiency, Substitution (eds E. Nieschlag & H.M. Behre), 2nd edn. pp. 329-348, Springer, Heidelberg.
8. Bronson, W.D., Walker, S.E., Hillman, L.S., Keisler, D., Hoyt, T. & Allen, S.H. (1998) Bone mineral density and biochemical markers of bone metabolism in ankylosing spondylitis. Journal of Rheumatology, 25, 929-935.
9. Burris, A.S., Banks, S.M., Carter, C.S., Davidson, J.M. & Sherins, R.J. (1992) A long-term, prospective study of the physiologic and behavioral effects of hormone replacement in untreated hypogonadal men. Journal of Andrology, 13, 297-304.
10. Carter, H.B., Pearson, J.D., Metter, E.J., Brant, L.J., Chan, D.W., Andres, R., Fozard, J.L. & Walsh, P.C. (1992) Longitudinal evaluation of prostate-specific antigen levels in men with an without prostate disease. Journal of the American Medical Association, 267, 2215-2220.
11. De Biasi, F., Londero, D., Praturlon, S., Di Donna, A., Feruglio, G.A. & Guerra, U.P. (1996) Longitudinal evaluation of prostate-specific antigen levels in a case-control study. European Urology, 29,184-188.
12. Editorial (1989) Transdermal testosterone. Lancet, 1, 652-653.
13. Findlay, J.C., Place, V.A. & Snyder, P.J. (1987) Transdermal delivery of testosterone. Journal of Clinical Endocrinology and Metabolism, 64, 266-268.
14. Finkelstein, J.S. (1998) Androgens and bone metabolism. In: Testosterone: Action, Deficiency, Substitution (eds E. Nieschlag & H.M. Behre), 2nd edn, pp. 187-207. Springer, Heidelberg.
15. Gooren, L.J. (1994) A ten-year safety study of the oral androgen testosterone undecanoate. Journal of Andrology, 15, 212-215.
16. Hajjar, R.R., Kaiser, F.E. & Morley, J.E. (1997) Outcomes of long-term testosterone replacement in older hypogonadal males: a retrospective analysis. Journal of Clinical Endocrinology and Metabolism, 82, 3793-3796.
17. Jordan, W.P. (1997) Allergy and tropical irritation associated with transdermal testosterone administration: a comparison of scrotal and nonscrotal transdermal systems. American Journal of Contact and Dermatology, 8, 108-113.
18. Krieg, M. & Tunn, S. (1990) Androgens and human benign prostatic hyperplasia (BPH). In: Testoterone: Action, Deficiency, Substitution (eds E. Nieschlag & H.M. Behre), pp. 219-244. Springer, Heidelberg.
19. Leifke, E., Körner, H.-Ch., Link, T.M., Behre, H.M., Peters, P.E. & Nieschlag, E. ( 1998) Effects of testosterone replacement therapy on cortical and trabecular bone mineral density, vertebral body area and paraspinal muscle area in hypogonadal men. European Journal of Endocrinology, 138, 51-58.
20. Meikle, W.A, (1998) A permeation-enhanced non-scrotal testosterone transdermal system for the treatment of male hypogonadism. In: Testosterone: Action, Deficiency, Substitution (eds E. Nieschlag & H.M. Behre), 2nd edn. pp. 389-422. Springer, Heidelberg.
21. Meikle, A.W., Arver, S., Dobs, A.S., Adolfsson, J., Sanders, S.W., Middleton, R.G., Stephenson, R.A., Hoover, D.R., Rajaram, L. & Mazer, N.A. (1997) Prostate size in hypogonadal men treated with a nonscrotal permeation-enhanced testosterone transdermal system. Urology, 49, 191-196.
22. Nieschlag, E., Wang, C., Handelsman, D.J., Swerdloff, R.S., Wu, F., Einer-Jensen, N. & Waites, G. (1992) Guidelines for the Use of Androgens. WHO, Geneva.
23. Nieschlag, E. & Behre, H.M. (1998) Pharmacology and clinical uses of testosterone. In: Testosterone: Action, Deficiency, Substitution (eds E. Nieschlag & H.M. Behre), 2nd edn. pp. 293-328. Springer, Heidelberg.
24. Nieschlag E. (1998) If testosterone, which testosterone? Which androgen regimen should be used for supplementation in older men? Formulation, dosing, and monitoring issues. Journal of Clinical Endocrinology and Metabolism, 83, 3443-3445.
25. Sih, R., Morley, J.E., Kaiser, F.E., Perry, H.M., Patrick, P. & Ross, C. (1997) Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial. Journal of Clinical Endocrinology and Metabolism, 82, 1661-1667.
26. Vermeulen, A. & Deslypere, J.P. (1985) Long-term transdermal dihydrotestosterone therapy: effects on pituitary gonadal axis and plasma lipoproteins. Maturitas, 7, 281-287.